PHARMARIS IROSORB

LIVE

Serial Number

99474441

Owner

Pharmaris Canada Inc.

Attorney

Nyall Engfield

Filing Date

Nov 1, 2025

Add to watchlist:

No watchlists yet

+ Create New Watchlist

PHARMARIS IROSORB Trademark

Serial Number: 99474441 • Registration: 8301680

PHARMARIS IROSORB is a trademark filed by Pharmaris Canada Inc. on November 1, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Pharmaris Canada Inc. (19 trademarks)

Surrey BC V3W8J9 , CA

Entity Type: 03

Legal Representation

Attorney of Record

Nyall Engfield

11,489 trademarks filed View all →

Correspondence Address

Pharmaris Canada Inc.

102-8310 130 Street

Surrey, BC, V3W8J9

Canada

Trademark Details

Filing Date

November 1, 2025

Registration Date

June 16, 2026

Published for Opposition

April 28, 2026

Goods & Services

Dietary supplements consisting primarily of iron; Nutritional supplements consisting primarily of iron; Nutritional supplements for increasing iron; Dietary and nutritional supplements for iron deficiency

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 16, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Jun 16, 2026 R.PR

WITHDRAWAL OF ATTORNEY GRANTED

Jun 11, 2026 WOAG

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

Jun 11, 2026 WOAR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 28, 2026 NPUB

PUBLISHED FOR OPPOSITION

Apr 28, 2026 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 22, 2026 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 30, 2026 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 30, 2026 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 30, 2026 CRFA

ASSIGNED TO LIE

Mar 30, 2026 ALIE

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

Mar 24, 2026 ERSI

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Mar 18, 2026 GNS3

LETTER OF SUSPENSION E-MAILED

Mar 18, 2026 GNSL

SUSPENSION LETTER WRITTEN

Mar 18, 2026 CNSL

ASSIGNED TO EXAMINER

Mar 16, 2026 DOCK

APPLICATION FILING RECEIPT MAILED

Nov 1, 2025 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 1, 2025 NWOS

NEW APPLICATION ENTERED

Nov 1, 2025 NWAP

Related Trademarks

More from this Owner

PHARMARIS I-MAX THERAPEUTIC 150

PHARMARIS I-MAX THERAPEUTIC 150

PHARMARIS IRONSOM FORTE

PHARMARIS IRONSOM FORTE

PHARMARIS I-MAX

PHARMARIS I-MAX THERAPEUTIC 150

PHARMARIS I-MAX THERAPEUTIC 150

PHARMARIS I-MAX

PHARMARIS IRONSOM FORTE

PHARMARIS IRONSOM FORTE

More in Same Class

MELAXIN

PLANTED LABS

LIFE AFTER THE PILL

LIFE AFTER THE PILL

VEROA

PHARMARIS I-MAX THERAPEUTIC 150

PHARMARIS I-MAX THERAPEUTIC 150

BLINK PROTEIN